Cervical Artery Dissection in Stroke Study | Clinical Trial - CADISS


The goal of the trial was to compare the relative effectiveness of antiplatelet therapy versus anticoagulation therapy in patients with extracranial carotid and vertebral artery dissection.

Contribution to the Literature: The CADISS trial suggests that there is no difference between the two strategies (antiplatelet vs. anticoagulation) in mitigating the risk of recurrent stroke at 3 months; the risk of recurrent stroke is also low.